|
| 36152109 | Identifying meaningful change on PROMIS short forms in cancer patients: a comparison of item response theory and classic test theory frameworks. | Qual Life Res | 2023 |
| 37541263 | Surgical versus non-surgical management for patients with malignant bowel obstruction (S1316): a pragmatic comparative effectiveness trial. | Lancet Gastroenterol Hepatol | 2023 |
| 37339926 | Baseline Quality of Life is a Strong and Independent Prognostic Factor for Overall Survival in Metastatic Colorectal Cancer. | Cancer Control | 2023 |
| 37428354 | Correction to: Establishing a common metric for patient-reported outcomes in cancer patients: linking patient reported outcomes measurement information system (PROMIS), numerical rating scale, and patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE). | J Patient Rep Outcomes | 2023 |
| 33213233 | Impact of Massage Therapy on the Quality of Life of Hospice Patients and Their Caregivers: A Pilot Study. | J Palliat Care | 2022 |
| 35569438 | Clustering of EORTC QLQ-C30 health-related quality of life scales across several cancer types: Validation study. | Eur J Cancer | 2022 |
| 35928285 | A prospective, randomized trial of patient-reported outcome measures to drive management decisions in hematology and oncology. | Contemp Clin Trials Commun | 2022 |
| 34890060 | Decision aids for localized prostate cancer in diverse minority men: Primary outcome results from a multicenter cancer care delivery trial (Alliance A191402CD). | Cancer | 2022 |
| 34882169 | Efficacy of Treatment With Armodafinil for Cancer-Related Fatigue in Patients With High-grade Glioma: A Phase 3 Randomized Clinical Trial. | JAMA Oncol | 2022 |
| 35088616 | Effects of patient-reported outcome assessment order. | Clin Trials | 2022 |
| 34842060 | A feasibility study of virtual group therapy to improve quality of life of cancer caregivers. | J Psychosoc Oncol | 2022 |
| 34600739 | Stoma location and ostomy-related quality of life among cancer survivors with ostomies: A pooled analysis. | Am J Surg | 2022 |
| 34364834 | Disparities in older adult accrual to cancer trials: Analysis from the alliance for clinical trials in oncology (A151736). | J Geriatr Oncol | 2022 |
| 32951293 | Expanding Beyond Maximum Grade: Chemotherapy Toxicity over Time by Age and Performance Status in Advanced Non-Small Cell Lung Cancer in CALGB 9730 (Alliance A151729). | Oncologist | 2021 |
| 33718787 | Do Missing Values Influence Outcomes in a Cross-sectional Mail Survey? | Mayo Clin Proc Innov Qual Outcomes | 2021 |
| 33852323 | Electronic Geriatric Assessment: Is It Feasible in a Multi-Institutional Study That Included a Notable Proportion of Older African American Patients? (Alliance A171603). | JCO Clin Cancer Inform | 2021 |
| 33544249 | Correction to: Establishing a common metric for patient-reported outcomes in cancer patients: linking patient reported outcomes measurement information system (PROMIS), numerical rating scale, and patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE). | J Patient Rep Outcomes | 2021 |
| 33486637 | How much time do we have? Longitudinal perception of prognosis in newly-diagnosed high grade glioma patients and caregivers compared to clinicians. | J Neurooncol | 2021 |
| 33802509 | Genetic Predictors of Chemotherapy-Induced Peripheral Neuropathy from Paclitaxel, Carboplatin and Oxaliplatin: NCCTG/Alliance N08C1, N08CA and N08CB Study. | Cancers (Basel) | 2021 |
| 33578652 | Genetic Variations and Health-Related Quality of Life (HRQOL): A Genome-Wide Study Approach. | Cancers (Basel) | 2021 |
| 33604969 | Preemptive Versus Reactive Topical Clobetasol for Regorafenib-Induced Hand-Foot Reactions: A Preplanned Analysis of the ReDOS Trial. | Oncologist | 2021 |
| 35047215 | The hidden curriculum in health care academia: An exploratory study for the development of an action plan for the inclusion of diverse trainees. | J Clin Transl Sci | 2021 |
| 34533663 | Score equivalence of paper-, tablet-, and interactive voice response system-based versions of PROMIS, PRO-CTCAE, and numerical rating scales among cancer patients. | J Patient Rep Outcomes | 2021 |
| 34362097 | N-Terminal Pro Brain Natriuretic Peptide, sST2, and Galectin-3 Levels in Breast Cancer Survivors. | J Clin Med | 2021 |
| 34255538 | Association of Fatigue and Outcomes in Advanced Cancer: An Analysis of Four SWOG Treatment Trials. | JCO Oncol Pract | 2021 |
| 33258687 | Composite grading algorithm for the National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE). | Clin Trials | 2021 |
| 33079411 | A randomized study to prevent lymphedema in women treated for breast cancer: CALGB 70305 (Alliance). | Cancer | 2021 |
| 33079393 | Health-related quality of life outcomes for the LEAP study-CALGB 70305 (Alliance): A lymphedema prevention intervention trial for newly diagnosed breast cancer patients. | Cancer | 2021 |
| 31122027 | Intellectual Equipoise and Challenges: Accruing Patients With Advanced Cancer to a Trial Randomizing to Surgical or Nonsurgical Management (SWOG S1316). | Am J Hosp Palliat Care | 2020 |
| 31876902 | Clinician vs Patient Reporting of Baseline and Postbaseline Symptoms for Adverse Event Assessment in Cancer Clinical Trials. | JAMA Oncol | 2020 |
| 32031887 | Multisite, Randomized Trial of Early Integrated Palliative and Oncology Care in Patients with Advanced Lung and Gastrointestinal Cancer: Alliance A221303. | J Palliat Med | 2020 |
| 32018185 | Neurological safety of oxaliplatin in patients with uncommon variants in Charcot-Marie-tooth disease genes. | J Neurol Sci | 2020 |
| 32007209 | International standards for the analysis of quality-of-life and patient-reported outcome endpoints in cancer randomised controlled trials: recommendations of the SISAQOL Consortium. | Lancet Oncol | 2020 |
| 31852811 | Intergroup Randomized Phase III Study of Postoperative Oxaliplatin, 5-Fluorouracil, and Leucovorin Versus Oxaliplatin, 5-Fluorouracil, Leucovorin, and Bevacizumab for Patients with Stage II or III Rectal Cancer Receiving Preoperative Chemoradiation: A Trial of the ECOG-ACRIN Research Group (E5204). | Oncologist | 2020 |
| 33305344 | Establishing a common metric for patient-reported outcomes in cancer patients: linking patient reported outcomes measurement information system (PROMIS), numerical rating scale, and patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE). | J Patient Rep Outcomes | 2020 |
| 33409496 | Calculating the net clinical benefit in neuro-oncology clinical trials using two methods: quality-adjusted survival effect sizes and joint modeling. | Neurooncol Adv | 2020 |
| 32677021 | Patient-reported quality-of-life outcomes in relation to provider-assessed adverse events during head and neck radiotherapy. | J Patient Rep Outcomes | 2020 |
| 32234612 | Comparative analysis of acute toxicities and patient reported outcomes between intensity-modulated proton therapy (IMPT) and volumetric modulated arc therapy (VMAT) for the treatment of oropharyngeal cancer. | Radiother Oncol | 2020 |
| 32402542 | Symptom relief and quality of life after combined partial hepatectomy and cyst fenestration in highly symptomatic polycystic liver disease. | Surgery | 2020 |
| 31586248 | Prospective longitudinal cohort study of patient recovery after major gastrointestinal surgery: is there a difference between minimally invasive and open approaches? | Surg Endosc | 2020 |
| 29649081 | Psychometric Testing of the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-Chemotherapy-Induced Peripheral Neuropathy 20-Item Scale Using Pooled Chemotherapy-Induced Peripheral Neuropathy Outcome Measures Standardization and Alliance for Clinical Trials in Oncology A151408 Study Data. | Cancer Nurs | 2019 |
| 31685708 | Author response: Age and sex differences in burnout, career satisfaction, and well-being in US neurologists. | Neurology | 2019 |
| 31378618 | Spirituality and Emotional Distress Among Lung Cancer Survivors. | Clin Lung Cancer | 2019 |
| 30985599 | A Case Management System for Integrating Patient-reported Outcome Assessment in Clinical Practice: The Beacon Tool. | Med Care | 2019 |
| 31108240 | Improving attribution of adverse events in oncology clinical trials. | Cancer Treat Rev | 2019 |
| 30550729 | Impact of hospital hospitality house programs on quality of life and mood of patients and caregivers after hematopoietic stem cell transplant. | Hematol Oncol Stem Cell Ther | 2019 |
| 30646679 | The feasibility of individualized prehabilitation for patients undergoing gastrointestinal cancer resections: a pilot study. | Minerva Chir | 2019 |
| 28921241 | Evaluating the efficacy of vaginal dehydroepiandosterone for vaginal symptoms in postmenopausal cancer survivors: NCCTG N10C1 (Alliance). | Support Care Cancer | 2018 |
| 30081846 | The comparative effectiveness of decision aids in diverse populations with early stage prostate cancer: a study protocol for a cluster-randomized controlled trial in the NCI Community Oncology Research Program (NCORP), Alliance A191402CD. | BMC Cancer | 2018 |
| 30191850 | Statistical analysis of patient-reported outcome data in randomised controlled trials of locally advanced and metastatic breast cancer: a systematic review. | Lancet Oncol | 2018 |